These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32109808)

  • 41. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 42. Methadone replacement therapy: tried, tested, effective?
    Robertson JR; Daniels AM
    J R Coll Physicians Edinb; 2012 Jun; 42(2):133-8. PubMed ID: 22693699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methadone and metabolite urine concentrations in patients maintained on methadone.
    Preston KL; Epstein DH; Davoudzadeh D; Huestis MA
    J Anal Toxicol; 2003 Sep; 27(6):332-41. PubMed ID: 14516485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
    Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
    Zhou K; Zhuang G
    Addict Behav; 2014 Jan; 39(1):22-9. PubMed ID: 24090627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stigma from the Viewpoint of the Patient.
    Woods JS; Joseph H
    J Addict Dis; 2015; 34(2-3):238-47. PubMed ID: 26076048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationships between perceived social support and retention among patients in methadone maintenance treatment in mainland China.
    Zhou K; Li H; Wei X; Li X; Zhuang G
    Psychol Health Med; 2017 Apr; 22(4):493-500. PubMed ID: 26987512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
    Hiltunen AJ; Eklund C; Borg S
    Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid determination of methadone and its major metabolite in biological fluids by gas-liquid chromatography with thermionic detection for maintenance treatment of opiate addicts.
    Chikhi-Chorfi N; Pham-Huy C; Galons H; Manuel N; Lowenstein W; Warnet JM; Claude JR
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 718(2):278-84. PubMed ID: 9840439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perceived barriers to methadone maintenance treatment among Iranian opioid users.
    Khazaee-Pool M; Moeeni M; Ponnet K; Fallahi A; Jahangiri L; Pashaei T
    Int J Equity Health; 2018 Jun; 17(1):75. PubMed ID: 29890990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of urine monitoring in methadone maintenance.
    Havassy B; Hall S
    Am J Psychiatry; 1981 Nov; 138(11):1497-500. PubMed ID: 7294222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An investigation of an open-access model for scaling up methadone maintenance treatment.
    Madden LM; Farnum SO; Eggert KF; Quanbeck AR; Freeman RM; Ball SA; Schottenfeld RS; Shi JM; Savage ME; Barry DT
    Addiction; 2018 Aug; 113(8):1450-1458. PubMed ID: 29453891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study.
    Luo C; Sanger N; Zielinski L; Bhatt M; Shahid H; Shams I; Mouravska N; Luetam S; Hudson J; Thabane L; Samaan Z
    Harm Reduct J; 2019 Feb; 16(1):13. PubMed ID: 30744638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
    Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM;
    Harm Reduct J; 2016 Apr; 13():12. PubMed ID: 27048152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
    Lua PL; Talib NS
    Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China.
    Zhou K; Li H; Wei X; Li X; Zhuang G
    J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.